Bibliografia sulla sindrome HELLP
1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in
pregnancy. Am J Obstet Gynecol 1982; 142: 159-67
2. Wolf JL. Liver disease in pregnancy. Med Clin North Am 1996; 80: 1167-87
3. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternalperinatal outcome associated with the syndrome of
hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501-9
4. Martin JN Jr, Blake PG, Lowry SL, Perry KG Jr, Files JC, Morrison JC. Pregnancy complicated by preeclampsia-eclampsia with the
syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol
1990; 76: 737-41
5. Martin JN Jr, Rinehart K, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis
by HELLP syndrome classification. Am J Obstet Gynecol 1999; 180: 1373-84
6. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with
hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000-6
7. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver
enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996; 175: 460-4
8. Martin JN Jr, Thigsen BD, Rose CH, Cushman J, Moore A, May WL. Maternal benefit of high-dose intravenous corticosteroid
therapy for HELLP. Am J Obstet Gynecol 2003; 189: 830-4
9. Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets.
Am J Obstet Gynecol 1993; 168: 1682-90
10. Drakeley AJ, LeRoux PA, Anthony J, Penny J. Acute renal failure complicating severe preeclampsia requiring admission to an
obstetric intensive care unit. Am J Obstet Gynecol 2002; 186: 253-6
11. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’
gestation: does HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999;
180: 221-5
12. Van Pampus MG, Wolf H, Westenberg SM, van der Post JA, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant
management of the HELLP syndrome compared with preeclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol
1998; 76: 31-6
13. Van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following temporizing management of the (H)ELLP syndrome.
Hypertens Pregnancy 2000; 19: 211-20
14. Kang AH, Graves CR. Herpes simplex hepatitis in pregnancy: a case report and review of the literature. Obstet Gynecol Surv 1999;
54: 463-8
37
15. Rebulla P. Platelet transfusion trigger in difficult patients. Transfus Clin Biol 2001;8:249-54)(Practice guidelines for periopera-
tive blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on
Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208
16. ACOG technical bulletin. Blood component therapy. Number 199 – November 1994 (replaces no. 78, July 1984). Committee on
Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995;48:233-8
17. O’Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP
(hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am J Obstet
Gynecol 2002;186:475-9
18. Ministero della Salute Dipartimento Della Qualità Direzione Generale Della Programmazione Sanitaria, Dei Livelli Di Assisten-
za E Dei Principi Etici Di Sistema Ufficio III Documento Di Integrazione Ed Indirizzo Relativo Alla Raccomandazione Per La
Prevenzione Della Morte Materna Correlata Al Travaglio e/o Parto. 2006
19. Society of Obstetric Medicine of Australia and New Zeland. Guidelines for the management of hypertensive disorders of
pregnancy; 2008
20. Hofmeyr GJ, Mohlala BK. Hypovolaemic shock. Best Pract Res Clin Obstet Gynaecol 2001; 15: 645-62
21. Alderson P, Schierhout G, Roberts I, Bunn F. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane
Database Syst Rev 2000; 2: CD000567
22. Roberts I, Alderson P, Bunn F, et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients.Cochrane
Database Syst Rev 2004; 4: CD000567
23. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007
24. Liumbruno G, Bennardello F, Lattanzio A, et al. Raccomandazioni per l’uso dell’albumina. In: Liumbruno G, Bennardello F,
Lattanzio A, et al, editors. Raccomandazioni SIMTI sul Corretto Utilizzo degli Emocomponenti e dei Plasmaderivati, Milano,
Italia: SIMTI Servizi Srl; 2008. p. 45-58
25. Redman CWG, Sargent IL. Preeclampsia and the systemic inflammatory response. Semin Nephrol 2004; 24: 565-70
26. Sibai BM. The HELLP Syndrome (hemolysis, elevated liver enzymes, and low platelets):
27. Crane JMG, Tabarsi B, Hutchens D. The maternal benefits of corticosteroids with HELLP syndrome. J Obstet Gynaecol Can 2003;
25: 650-5
28. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets)
syndrome in pregnancy. Cochrane Database Syst Rev. 2010;9:CD008148
29. NICE clinical guideline. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. August 2010
30. Yalcin OT, Sener T, Hassa H, Ozalp S, Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J
Gynaecol Obstet 1998; 61: 141-8
31. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic
review and meta-analyses. Am Heart J 2008;156:918-930
32. Knapen M, VanAltena A, Peters WHM, Merkus HMWM, Jansen JJ, Steegers EAP. Liver function following pregnancy complicated
by the HELLP syndrome. Br J Obstet Gynaecol 1998; 105: 1208-10
33. Chames MC, Haddad B, Barton JR, Livingston JC, Sibai BM. Subsequent pregnancy outcome in women with a history of HELLP
syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol 2003;188:1504-7
34. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders
and related problems. Cochrane Database Syst Rev. 2010;(8):CD001059.
